Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Hisse Senetlerindeki Sıralama #28845
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Hisse Fiyatı
$1.89
Son senkronizasyon: 2022-12-16
Piyasa Değeri
$24.38M
Değişim (1 gün)
8.62%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Yumanity Therapeutics, Inc. (YMTX)

Kategori

Yumanity Therapeutics, Inc. (YMTX) için hisse bölünme geçmişi
Yumanity Therapeutics, Inc. hissesi (sembol: YMTX) toplamda 0 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Aug 19, 2026 tarihinde gerçekleşmiştir.
Aug 19, 2026 tarihinden önce alınan bir YMTX hissesi bugün 0 YMTX hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH